Bangalore, March 3, 2016: India’s biggest Nanotechnology event, returns to Bangalore this week for the 8th time.

A key highlight of the inaugural was the presentation of the Prof. C.N.R. Rao Bangalore INDIA NANO Science Award to Prof. Dr. V. Ramgopal Rao - P. K. Kelkar Chair Professor in the Department of Electrical Engineering and the Chief Investigator for the Centre of Excellence in Nanoelectronics project at IIT Bombay for the exceptional work carried out in the Nano electronics space.
Another feature of this edition was the launch of India’s first CVD Reactor by Prof. CNR Rao as part of the Product and Technology exhibition.  (Chemical vapor deposition (CVD) reactors are used in applications that involve the deposition of a layer or layers of a substance onto a surface)
Showcasing innovative nanotechnology adopted by over 45 distinct exhibitors in Nanotechnology and Allied Sectors, the  tradeshow  saw participation from 14 organizations under DST NANO MISSION Pavilion, Institutes of National Importance like IITs, NIT, IISc, INST along with other corporates.
___________________________________
LIVE Webcast here
___________________________________
The first keynote  lecture conducted by Prof. Dr. Clement Sanchez focused on how mankind has evolved using tools from stones to copper, iron, glass and now designing and applying nano materials across sectors. The second lecture led by Prof. Young Hee Lee, Professor of Physics, Sungkyunkwan University, South Korea gave an insight on the introduction of new materials for semiconducting by synthesizing in labs. In addition, he took the audience through the Nano carbon world and the characteristics of CNT and Graphene.
Day 1 also comprised of two essential sessions Clean Water Technology and Healthcare solutions. The Clean Water Technology enlightened the attendees on new nanotechnology based solutions that are needed for sensing and remote monitoring to ensure that solutions are functioning and people are benefiting. The Healthcare session covered recent results on the development of CNTs using biological receptors such as  antibodies and binding proteins.